Y, Z., J, X., J, W., L, X., J, L., HC, G., . . . MJ, M. (2026). mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity. Proceedings of the National Academy of Sciences of the United States of America, 123(28), e2525718123. https://doi.org/10.1073/pnas.2525718123
Chicago Style (17th ed.) CitationY, Zeng, et al. "MRNA Lipid Nanoparticle Cancer Vaccine Platform Delivering Multiple STING Activators for Enhanced Antitumor Activity." Proceedings of the National Academy of Sciences of the United States of America 123, no. 28 (2026): e2525718123. https://doi.org/10.1073/pnas.2525718123.
MLA (9th ed.) CitationY, Zeng, et al. "MRNA Lipid Nanoparticle Cancer Vaccine Platform Delivering Multiple STING Activators for Enhanced Antitumor Activity." Proceedings of the National Academy of Sciences of the United States of America, vol. 123, no. 28, 2026, p. e2525718123, https://doi.org/10.1073/pnas.2525718123.